PETACH TIKVA, Israel–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, announced today it has been granted...
TORONTO, Feb. 18, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”), a company focused on the research, development and commercialization of novel cannabinoid-based and life sciences products, is pleased to provide an update on the...
Pivotal Phase 3 trial of zilucoplan in gMG ongoing, with top-line results expected in early 2021 February 18, 2020 07:00 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced that full results from...
Various alternatives to a daily pill for HIV pre-exposure prophylaxis (PrEP) have are being evaluated to ease the burden on patients and increase adherence to the regimen. The National Institutes of Health (NIH) has launched the first clinical trial evaluating the...
Data Presented at the 4th Annual World Congress of Cutaneous Lymphomas in Barcelona, Feb 2020 VANCOUVER, British Columbia, Feb. 18, 2020 (GLOBE NEWSWIRE) — WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”), a clinical stage pharmaceutical...
Email
Text